The technetium index, based on the sum of the count rates over several joints, has been shown to correlate with some clinical measurements of disease severity (Oka, Rekonen, and Ruotsi, 1971; Huskisson and others, 1973) but has not been found to be responsive to anti-inflammatory drug therapy, not even to corticosteroids (Berry and Huskisson, 1974 ).
Methods
Twenty-two patients with classical or definite rheumatoid arthritis (RA) by the A.R.A. criteria (Committee of the American Rheumatism Association, 1959) were studied; all had active disease which had failed to respond to, or progressed despite, optimal anti-inflammatory drug therapy. Eleven patients were treated with penicillamine (doses increasing by 250 mg fortnightly up to a maintenance dose of 1 g daily) and anti-inflammatory drugs, and 11 patients continued with anti-inflammatory drugs alone.
The technetium index was measured before the start of treatment and again after 6 months' treatment. Approximately 200p,Ci technetium were injected intravenously and count rates recorded 20 minutes later over both knees and both wrists. Each joint was counted for 20 seconds. The syringe was counted before and after injection, the difference between the two counts representing the dose given. stiffness, proximal interphalangeal joint size (Boardman and Hart, 1967) , and articular index (Ritchie and others, 1968) . Latex tests were carried out at the beginning and end ofthe study.
Changes in measurements within each group were analysed by Student's 't' test applied to paired data. Correlation coefficients were calculated for changes in technetium index and changes in other measurements. Student's 't' test was also used to test the comparability of the two groups at the start of the study.
Results
There was no significant difference between the two groups in any of the measurements made at the start of the study. There was a significant reduction in technetium index in patients receiving penicillamine but not in those receiving anti-inflammatory drugs (Table) . There was also a significant reduction in latex test titres in the penicillamine group, but not in the anti-inflammatory group (t = 3-46; P < 0-01).
Changes in technetium index showed a significant correlation with improvement in pain (r = 0O81; P < 0-01) andjoint circumference (r = 060; P < 0 05), but not with articular index, duration of morning stiffness, or changes in latex test titre.
Discussion
Objective measurements of the severity and course of rheumatoid arthritis are badly needed especially in view of the unpredictable course of the disease and the striking effects which symptomatic therapy including placebos can have on the subjective manifestations. The technetium index seems to offer such a 
